Study of Validity of PC-3 Derived Xenograft Tumor Model in Athymic Nude Mice for Targeting Therapy of Androgen Receptors in Preclinical Studies of Prostate Cancer
Background: Androgen receptors (AR) play an important role in proliferation of cancerous prostatic cells and prevention of apoptotic signaling. Current drugs cannot inhibit the activity of these receptors very well. Establishment of appropriate animal models is essential for discovery of new drugs...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Tehran University of Medical Sciences
2016-10-01
|
Series: | Basic & Clinical Cancer Research |
Subjects: | |
Online Access: | https://bccr.tums.ac.ir/index.php/bccrj/article/view/19 |
id |
doaj-70732cfd3a5f4470b2c1f15863dcc3af |
---|---|
record_format |
Article |
spelling |
doaj-70732cfd3a5f4470b2c1f15863dcc3af2021-04-04T07:07:05ZengTehran University of Medical SciencesBasic & Clinical Cancer Research2228-65272228-54662016-10-0132Study of Validity of PC-3 Derived Xenograft Tumor Model in Athymic Nude Mice for Targeting Therapy of Androgen Receptors in Preclinical Studies of Prostate CancerSamad Muhammadnejad0Ahad Muhammadnejad1Zohreh Mazaheri2Farrokh Tirgari3Mohammad-Ali Oghabian4Maryam Kazem haghighi5Saeid Amanpour6Cancer Research Center, Cancer Institute, Tehran University of Medical Sciences, Tehran, IranCancer Research Center, Cancer Institute, Tehran University of Medical Sciences, Tehran, IranVali-e-Asr Reproductive Health Research Center, Tehran University of Medical Sciences, Tehran, IranCancer Research Center, Cancer Institute, Tehran University of Medical Sciences, Tehran, IranResearch Center for Sciences and Technology in Medicine, Tehran University of Medical Sciences Tehran, IranCancer Research Center, Cancer Institute, Tehran University of Medical Sciences, Tehran, IranCancer Research Center, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran, AND Vali-e-Asr Reproductive Health Research Center, Tehran University of Medical Sciences, Tehran, Iran Background: Androgen receptors (AR) play an important role in proliferation of cancerous prostatic cells and prevention of apoptotic signaling. Current drugs cannot inhibit the activity of these receptors very well. Establishment of appropriate animal models is essential for discovery of new drugs of target therapy in hormone dependent prostate cancer. Materials and Methods: Standard prostatic cancer cell line (PC-3) was injected heterotopically into 9 nude mice. After tumor formation they were excised and sent for histopathologic and AR expression studies by immunohistochemistry. Results: Histological characteristics of prostate cancer were confirmed. Androgen receptors had been expressed in 65 ± 25% of the xenograft tumor cells. Conclusions: This xenograft model is suitable for pharmacological and molecular studies of androgen dependent prostate cancer. https://bccr.tums.ac.ir/index.php/bccrj/article/view/19Androgen receptorprostate cancerxenograft modelAthymic nude mice |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Samad Muhammadnejad Ahad Muhammadnejad Zohreh Mazaheri Farrokh Tirgari Mohammad-Ali Oghabian Maryam Kazem haghighi Saeid Amanpour |
spellingShingle |
Samad Muhammadnejad Ahad Muhammadnejad Zohreh Mazaheri Farrokh Tirgari Mohammad-Ali Oghabian Maryam Kazem haghighi Saeid Amanpour Study of Validity of PC-3 Derived Xenograft Tumor Model in Athymic Nude Mice for Targeting Therapy of Androgen Receptors in Preclinical Studies of Prostate Cancer Basic & Clinical Cancer Research Androgen receptor prostate cancer xenograft model Athymic nude mice |
author_facet |
Samad Muhammadnejad Ahad Muhammadnejad Zohreh Mazaheri Farrokh Tirgari Mohammad-Ali Oghabian Maryam Kazem haghighi Saeid Amanpour |
author_sort |
Samad Muhammadnejad |
title |
Study of Validity of PC-3 Derived Xenograft Tumor Model in Athymic Nude Mice for Targeting Therapy of Androgen Receptors in Preclinical Studies of Prostate Cancer |
title_short |
Study of Validity of PC-3 Derived Xenograft Tumor Model in Athymic Nude Mice for Targeting Therapy of Androgen Receptors in Preclinical Studies of Prostate Cancer |
title_full |
Study of Validity of PC-3 Derived Xenograft Tumor Model in Athymic Nude Mice for Targeting Therapy of Androgen Receptors in Preclinical Studies of Prostate Cancer |
title_fullStr |
Study of Validity of PC-3 Derived Xenograft Tumor Model in Athymic Nude Mice for Targeting Therapy of Androgen Receptors in Preclinical Studies of Prostate Cancer |
title_full_unstemmed |
Study of Validity of PC-3 Derived Xenograft Tumor Model in Athymic Nude Mice for Targeting Therapy of Androgen Receptors in Preclinical Studies of Prostate Cancer |
title_sort |
study of validity of pc-3 derived xenograft tumor model in athymic nude mice for targeting therapy of androgen receptors in preclinical studies of prostate cancer |
publisher |
Tehran University of Medical Sciences |
series |
Basic & Clinical Cancer Research |
issn |
2228-6527 2228-5466 |
publishDate |
2016-10-01 |
description |
Background: Androgen receptors (AR) play an important role in proliferation of cancerous prostatic cells and prevention of apoptotic signaling. Current drugs cannot inhibit the activity of these receptors very well. Establishment of appropriate animal models is essential for discovery of new drugs of target therapy in hormone dependent prostate cancer.
Materials and Methods: Standard prostatic cancer cell line (PC-3) was injected heterotopically into 9 nude mice. After tumor formation they were excised and sent for histopathologic and AR expression studies by immunohistochemistry.
Results: Histological characteristics of prostate cancer were confirmed. Androgen receptors had been expressed in 65 ± 25% of the xenograft tumor cells.
Conclusions: This xenograft model is suitable for pharmacological and molecular studies of androgen dependent prostate cancer.
|
topic |
Androgen receptor prostate cancer xenograft model Athymic nude mice |
url |
https://bccr.tums.ac.ir/index.php/bccrj/article/view/19 |
work_keys_str_mv |
AT samadmuhammadnejad studyofvalidityofpc3derivedxenografttumormodelinathymicnudemicefortargetingtherapyofandrogenreceptorsinpreclinicalstudiesofprostatecancer AT ahadmuhammadnejad studyofvalidityofpc3derivedxenografttumormodelinathymicnudemicefortargetingtherapyofandrogenreceptorsinpreclinicalstudiesofprostatecancer AT zohrehmazaheri studyofvalidityofpc3derivedxenografttumormodelinathymicnudemicefortargetingtherapyofandrogenreceptorsinpreclinicalstudiesofprostatecancer AT farrokhtirgari studyofvalidityofpc3derivedxenografttumormodelinathymicnudemicefortargetingtherapyofandrogenreceptorsinpreclinicalstudiesofprostatecancer AT mohammadalioghabian studyofvalidityofpc3derivedxenografttumormodelinathymicnudemicefortargetingtherapyofandrogenreceptorsinpreclinicalstudiesofprostatecancer AT maryamkazemhaghighi studyofvalidityofpc3derivedxenografttumormodelinathymicnudemicefortargetingtherapyofandrogenreceptorsinpreclinicalstudiesofprostatecancer AT saeidamanpour studyofvalidityofpc3derivedxenografttumormodelinathymicnudemicefortargetingtherapyofandrogenreceptorsinpreclinicalstudiesofprostatecancer |
_version_ |
1721543209724674048 |